As of 30 Sep 2025, 72 institutional investors reported holding $1,082,598,160 in principal (par value) of DEXCOM INC - NOTE 0.375% 5/1.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $21,000 | $1,390,494 | -$2,622,312 | 4662.45% | 2 |
| 2025 Q3 | $1,082,598,160 | $990,122,831 | +$24,075,121 | 91.18% | 72 |
| 2025 Q2 | $1,076,020,160 | $1,018,044,849 | -$19,471,572 | 93.91% | 71 |
| 2025 Q1 | $1,095,041,700 | $980,742,679 | -$5,910,379 | 89.25% | 69 |
| 2024 Q4 | $1,096,116,100 | $988,248,481 | +$4,221,546 | 89.78% | 68 |
| 2024 Q3 | $1,080,140,460 | $960,334,098 | +$65,587,822 | 88.52% | 66 |
| 2024 Q2 | $919,585,880 | $906,502,641 | +$906,511,764 | 97.84% | 61 |